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Abstract
Objectives To find a threshold body weight (BW) below
100 kg above which computed tomography pulmonary angi-
ography (CTPA) using reduced radiation and a reduced
contrast material (CM) dose provides significantly im-
paired quality and diagnostic confidence compared with
standard-dose CTPA.
Methods In this prospectively randomised study of 501 pa-
tients with suspected pulmonary embolism and BW <100 kg,
246 were allocated into the low-dose group (80 kVp, 75 ml
CM) and 255 into the normal-dose group (100 kVp, 100 ml
CM). Contrast-to-noise ratio (CNR) in the pulmonary trunk
was calculated. Two blinded chest radiologists independently
evaluated subjective image quality and diagnostic confidence.
Data were compared between the normal-dose and low-dose
groups in five BW subgroups.
Results Vessel attenuation did not differ between the normal-
dose and low-dose groups within each BW subgroup (P=1.0).
The CNRwas higher with the normal-dose compared with the
low-dose protocol (P<0.006) in all BW subgroups except for
the 90-99 kg subgroup (P=0.812). Subjective image quality
and diagnostic confidence did not differ between CT protocols
in all subgroups (P between 0.960 and 1.0).
Conclusions Subjective image quality and diagnostic confi-
dence with 80 kVp CTPA is not different from normal-dose
protocol in any BW group up to 100 kg.
Key Points
• 80 kVp CTPA is safe in patients weighing <100 kg
• Reduced radiation and iodine dose still provide high vessel
attenuation
• Image quality and diagnostic confidence with low-dose
CTPA is good
• Diagnostic confidence does not deteriorate in obese patients
weighing <100 kg
Keywords Angiography, computed tomography . Pulmonary
embolism . Image quality . Radiation dose . Prospective
randomised trial
Introduction
In recent years, low tube voltage has been shown to be a
powerful tool for radiation dose reduction with computed
tomography (CT) angiographic applications. Image quality
of such protocols has been thoroughly investigated in virtually
all body regions. Several experimental and clinical studies
focused on CT pulmonary angiography (CTPA) because the
low X-ray absorption of aerated lungs facilitates low-dose
techniques by introducing lesser noise increase comparedwith
abdominal applications [1–5]. It has been established that
protocols at 100 kVp tube voltage provide very similar image
quality to the formerly used 120 kVp and 140 kVp techniques
at a significantly lower radiation dose. As a consequence, 100
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kVp tube energy is becoming more widely accepted as the
standard for CTPA.
In the last decade, a tube voltage of 80 kVp has also been
introduced for CTPA. One might apply low kVp at a constant
iodine delivery rate solely for further reduction of radiation
dose, which can reach 30-40 %, compared with 100 kVp
protocols. A more interesting approach is to use the increased
iodine attenuation at 80 kVp to reduce the volume of admin-
istered contrast material (CM) to the patient. The combination
of lower radiation dose and a reduced CM dose at 80 kVp CT
angiography is potentially valuable, especially in younger
patients and in elderly subjects with impaired renal function,
not only for the lungs but also for other body regions [6–16].
Increased noise is a known potential disadvantage of the
80 kVp technique, which might impair its applicability in
patients with higher body weight (BW) or body mass index
(BMI). There is no consensus in the community regarding the
threshold to which 80 kVp CTPA protocols can be used.
Although results from a phantom study predicted that image
quality is acceptable for diagnosis in a patient of up to 100 kg
BWand the first clinical experiences strengthened these data [3,
7, 17], most groups reserve 80 kVp CTPA for lean patients with
lowBMI or BWof less than 60-80 kg [9, 10, 18, 19].Moreover,
no prospective data have been reported on whether confidence
to rule in or out PE is affected by the low-dose protocol.
Herein we report on the image quality and diagnostic confi-
dence from a large-scale single-centre prospective randomised
study that compared a standard 100 kVp CTPA protocol with a
low-dose protocol at 80 kVp using both reduced radiation and a
reduced CM dose. Our aim was to find a threshold BW above
which the low-dose protocol provides significantly impaired
quality and diagnostic confidence compared with the standard
protocol in patients weighing up to 100 kg.
Materials and methods
Patients
The REDOPED (Reduced Dose in Pulmonary Embolism
Detection) trial was registered with ClinicalTrials.gov
(NCT01258140) and was powered to find significant differences
in accuracywith normal-dose and low-dose CTPA. The studywas
financially supported by the Stanley Thomas Johnson Foundation.
The authors had no contractual obligations towards this founda-
tion; they are neither its employees nor its consultants, and they
had full control of the data and the information in this manuscript.
The recruitment phase was open between September 2008
and December 2011 on a 7/24-h basis. Patients with indicated
CTPA for suspected pulmonary embolism (PE) at the emer-
gency department of the University Hospital Bern, Inselspital
and weighing less than 100 kg, who signed the informed
consent form, were randomly assigned to the normal-dose
(A) or low-dose (B) group. Exclusion criteria were age less
than 18 years, and contraindication to intravenous administra-
tion of iodinated contrast media. Patients weighing more than
100 kg were examined with the normal-dose protocol but
were not included in the study. Morphological data, including
BWand height, were recorded for all patients. Study subjects
were blinded to their group assignment.
Of the 2,714 patients who underwent CTPA in the study
period, only 504 were randomised. The high drop-out rate was
mainly due to high overload of CT personnel or patients de-
clining to participate in the study. Two of the 504 randomised
patients withdrew their consent in retrospect and one patient
was erroneously enrolled in the trial twice. Excluding these
three examinations, the data of 501 patients were included in
the final analysis. The normal-dose group consisted of 255
patients and the low-dose group of 246 patients (Fig. 1).
CT protocols
The same 16-row multidetector CT system (Somatom
Sensation 16; Siemens, Forchheim, Germany) was used for
CTPA during the entire study period. A collimation of 16×
0.75 mm, pitch of 1.15 and tube rotation time of 0.5 s were
kept unchanged in both groups. Automatic real-time tube
current modulation (CareDose4D, level “average”) was
switched on in all patients. In group A, we used a tube voltage
of 100 kVp and a quality reference tube current time product
of 100 mAs. In group B, the tube voltage was decreased to
80 kVp and the quality reference tube current time product
was increased to 150 mAs. These parameters were based on a
phantom study and provided good image quality in a smaller
patient collective [3, 7]. All patients had their arms lying
above the torso during the examination.
In both patient groups, the same standard iodinated contrast
medium at 300 mg I/ml (iobitridol, Xenetix 300; Guerbet,
Aulnay-sous-Bois, France) was administered in an antecubital
vein through a 20- or 18-gauge canula using a commercial
injector (CT Expres; Swiss Medical Care, Lausanne,
Switzerland). One hundred millilitres of CM was injected at a
flow rate of 4 ml/s in the normal-dose group (A) and 75 ml CM
was injected at 3 ml/s in the low-dose group (B), resulting in
equal injection times of 25 s. The contrast bolus was followed
by a saline chaser of 20 ml at the same injection rates as for the
CM. A bolus tracking technique (Care Bolus; Siemens) was
used for optimal opacification of the pulmonary arteries, where-
as image acquisition was started 4 s after reaching 100
Hounsfield units (HU) in the main pulmonary artery.
Transverse images were contiguously reconstructed at 5
and 1 mm using standard filtered back projection and a
smooth reconstruction kernel (B30f). Since maximum inten-
sity projection (MIP) images are routinely used in our institute
for aiding correct localisation of PE, overlapping MIP images
were calculated from the 1-mm-thick transverse slices in the
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coronal and transversal planes with 10-mm thickness at 2-mm
increments. All images were stored in a picture archiving and
communication system (PACS).
Analysis of objective image quality
The attenuation was measured by placing circular regions of
interest of 75-100 mm2 in the centre of the main pulmonary
artery on the 1-mm-thick transverse images (HUtrunk). Care
was taken to avoid false registration of the vessel wall. The
standard deviations of these CT numbers were used as image
noise. The attenuation measured in the paraspinal muscles at
the level of the pulmonary trunk served as background signal
(HUbackgr.). All measurements were performed in three differ-
ent slices and the averages were used for further calculation.
The contrast-to-noise ratio (CNR) was computed as
CNR=(HUtrunk – HUbackgr.)/noise.
Assessment of subjective image quality and diagnostic
confidence
All examinations were randomised and independently evalu-
ated by two expert chest radiologists (Z.S.F., A.C.) with 13
and 11 years of experience with CTPA. Although the readers
were not aware of patient data and technical parameters,
including CT tube voltage, the latter was sometimes obvious
from the image characteristics, preventing reliable blinding in
this respect. The observers rated overall image quality in the 1-
mm-thick transverse images using a five-grade scale (1=bad,
no diagnosis possible; 2=poor, diagnostic confidence signif-
icantly reduced; 3=moderate, but sufficient for diagnosis; 4=
good; 5=excellent). In the case of a score of 3 or less, readers
gave one or more reasons for deteriorated image quality: 1=
increased noise; 2=CM related, including too late or too early
bolus, rapid CM dilution due to low CM flow, high cardiac
output or shunt; 3=artefacts (respiratory, movement or metal-
lic); 4=pathology in the lung parenchyma, including tumour,
pneumonia or atelectasis; 5=significant pleural effusion; 6=
other cause with a brief description.
Readers were asked to report the presence or absence of
PE, along with the level of the affected artery (main, left or
right pulmonary, lobar, segmental, 1st and 2nd subsegmental)
and the confidence rate of the diagnosis (1=low; 2=medium;
3=high). An embolus was claimed to be present in the case of
an intraluminal filling defect in at least three consecutive 1-
mm-thick transverse images without major artefacts.
Observers entered their data into a table electronically.
During the image analysis, adjustments of the window level,
width, and magnification were allowed. The readers used both
the original transverse CT images and theMIP reconstructions
to localise PE. All image analyses were performed on high-
definition LCD monitors routinely used for reporting CT
images (ME355i2; Totoku Electric Co., Tokyo, Japan).
Radiation dose and figure of merit
The size-specific dose estimates (SSDE) were calculated for
all patients by multiplying the volume CT dose index by a
2210 were not randomized:
- 134 had exclusion criteria
- 298 could not give informed consent 
- 14 were in prison
- 1764 had unspecified reasons 
504 were randomized





255 were included in final analysis 246 were included in final analysis
3 were excluded:
- 1 was previously enrolled
- 2 withdrew consent
Fig. 1 Selection and allocation of
patients to the study groups
1870 Eur Radiol (2014) 24:1868–1877
size-specific correction factor as determined in the American
Association of Physicists in Medicine Report No. 204. Patient
size was characterised by the effective diameter of the chest
which was calculated as square root of the product of the
anterioposterior and lateral chest diameters in centimetres
[20]. Those diameters were measured on a transverse image
at the level of the pulmonary trunk and on the anterioposterior
CT radiograph (topogram).
In an effort to objectively analyse changes in image quality
as function of dose at various patient weights, we calculated a
figure of merit (FOM) as follows: FOM=CNR2/SSDE [3, 21].
Statistical analysis
Patients were classified into five subgroups on the basis of
their BW (<60 kg, 60-69 kg, 70-79 kg, 80-89 kg and 90-
99 kg). In order to find any significant disadvantage of the
low-dose protocol in obese patients, we also grouped study
subjects on the basis of their BMI (<25 kg/m2=underweight
and normal weight; 25-30 kg/m2=overweight; >30 kg/m2=
obesity). Except for gender, all patient data and image param-
eters were tested for normal distribution using the Shapiro-
Wilk W test. Parameters with normal distribution were com-
pared between the two dose groups and the various BW and
BMI subgroups using analysis of variance and post hoc tests.
Non-normally distributed data were compared with the
Kruskal-Wallis test and gender ratio was analysed with the
chi-squared test. The Kendall coefficient of concordance was
computed to assess the interobserver agreement regarding
overall image quality. Statistical analyses were performed
with Statistica software (StatSoft, Tulsa, OK). A P value of
less than 0.05 was considered statistically significant.
For the calculation of statistical power we estimated that
each BW group would consist of 100 patients, 50 for each
CTPA protocol. Supposing a standard deviation of 0.6, which
was based on our former experience with three- and five-grade
scales used for the confidence and image quality, a difference
of 0.34 between the means can be proved with a power of
0.8 at a two-sided alpha-level of 0.05.
Results
Overall patient data in the normal-dose and low-dose groups
Demographic and morphological data
Unexpectedly, significantly more women were included in the
low-dose group B than in the normal-dose group A (P=0.015;
Table 1). As a consequence, mean BWand height were higher
in the normal-dose group. The difference in BMI in favour of
the normal-dose group just reached statistical significance
(P=0.0497).
Number of PEs detected by the readers
The number of patients with PE did not differ significantly
between readers (P between 0.259 and 1.0) or between groups
A and B at any level of the pulmonary arterial tree (P between
0.376 and 0.952; Table 2). The salient inter-reader difference
for the lobar arteries was resolved during a consensus reading
and was due to discrepant interpretation of minimal involve-
ment of lobar arteries at their ramifications.
Overall subjective rating of quality and cause for reduced
image quality
The overall rating of subjective image quality was very similar
in groups A and B (P=0.156; Table 3). The Kendall coeffi-
cient of concordance between the readers for the subjective
quality grading was 0.630. The number of patients with de-
creased image quality (i.e. a grade of 3 or less) did not differ
significantly between the groups (P=0.403). Readers marked
a high noise level as a cause for impaired image quality more
frequently in the low-dose group than in the normal-dose
group (P<0.001).
Results in various BW groups
Gender ratio, age, BW, height and BMI were not significantly
different between groups A and B within each BW subgroup
(P between 0.069 and 1.0; Table 1).
Objective image quality
Attenuation in the pulmonary trunk decreased with increasing
BW in both groups A and B (P<0.001), but there was no
difference between the normal-dose and low-dose groups
within each BW subgroup (P=1.0; Fig. 2). Except for the
<60-kg (P=0.093) and the 90- to 99-kg groups (P=0.123),
image noise was higher in the low-dose group in all BW
classes (P<0.001). CNR was higher with the normal-dose
protocol compared with the low-dose protocol (P<0.006) in
all BW subgroups except for the 90- to 99-kg subgroup (P=
0.812).
Subjective image quality and diagnostic confidence
Both subjective image quality (P between 0.622 and
1.0) and diagnostic confidence (P between 0.960 and
1.0) were rated similarly with both CT protocols in all
BW subgroups (Figs. 2 and 3).
Radiation dose and FOM
SSDE was significantly lower with the low-dose CTPA pro-
tocol in all BW subgroups (P<0.001). The mean SSDE was
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6.8 mGy±1.2 in the normal-dose group and 4.8 mGy±1.0 in
the low-dose group (P<0.001), corresponding to a decrease of
30 %. SSDE was not significantly different between BW
subgroups above 60 kg within each CT protocol (P between
0.292 and 1.0).
FOM was in general higher at lower BWs than in
patients with higher BW, but there was no significant
difference between the BW subgroups above 70 kg with
the normal-dose protocol and above 80 kg at 80 kVp.
Within each BW subgroup, 100 kVp and 80 kVp CTPA
yielded very similar results (P between 0.724 and 1.0;
Fig. 2).
Results in various BMI groups
Although only patients weighing less than 100 kg were included
in this trial, 254 of 501 (50.7 %) study subjects were classified as
being overweight or obese (i.e. BMI >25 kg/m2; Table 4).
Radiation exposure was significantly lower in the low-dose
group than in the normal-dose group within all BMI subgroups
(P<0.001) and the samewas true for CNR in normal-weight and
overweight patients, but not in obese patients (P=0.518). FOM,
subjective image quality rating, and diagnostic confidence were
not different between CTPA protocols within each BMI sub-
group (P between 0.765 and 1.0).
Table 1 Descriptive statistics of demographic and morphological data of 501 study patients












Female/male (n) group A 107/148 30/9 26/22 22/42 21/47 8/28 <0.001
group B 130/116 42/8 43/26 21/31 17/37 7/14 <0.001
P 0.015 0.399 0.378 0.069 0.943 0.358
Age (years) group A 59.5±16.4 54.6±19.6 59.8±17.4 63.3±14.6 59.9±16.2 56.8±13.1 0.091
group B 57.4±17.8 55.0±19.4 59.2±19.9 59.8±16.4 56.6±16.8 53.2±16.0 0.433
P 0.168 1.0 1.0 0.986 0.991 0.997
Weight (kg) group A 74.6±13.3 53.1±4.8 65.1±3.0 74.2±3.0 83.7±2.9 94.3±3.4 <0.001
group B 70.6±13.4 52.2±5.7 63.9±3.0 74.7±2.8 83.6±3.0 93.1±3.4 <0.001
P <0.001 0.980 0.902 0.999 1.0 0.995
Height (cm) group A 170.5±9.3 163.2±8.1 167.7±8.3 170.4±7.8 173.1±8.4 177.3±9.0 <0.001
group B 168.3±9.1 162.0±7.6 166.8±6.8 170.0±7.9 172.1±9.9 174.6±9.5 <0.001
P 0.009 1.0 1.0 1.0 1.0 0.993
BMI (kg/m2) group A 25.7±4.2 20.0±2.1 23.3±2.3 25.7±2.5 28.1±2.7 30.2±3.6 <0.001
group B 24.9±4.4 19.9±2.4 23.1±1.8 26.0±2.6 28.5±3.4 30.8±3.6 <0.001
P 0.0497 1.0 1.0 1.0 1.0 1.0
Data are means and standard deviations except for gender. For each parameter, the third row contains P values for comparisons of study groups A and B
BMI body mass index
aP values for differences between various body weight groups
Table 2 Pulmonary emboli found by readers in both study groups
Localisation Normal-dose group Low-dose group P a
n=255 n=246
Reader 1 Reader 2 Reader 1 Reader 2
Main, left and right pulmonary arteries 8 7 6 6 0.766
Lobar arteries 18 25 17 25 0.952
Segmental arteries 43 40 39 34 0.531
1st subsegmental arteries 48 42 45 34 0.502
2nd subsegmental arteries 47 38 42 30 0.376
Numbers are patients with PE at the corresponding anatomical level of the pulmonary arterial tree
aP values for differences between the study groups are based on averaged data derived from the two independent readers
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Discussion
Former studies on low-dose CTPA were mainly retro-
spective in nature, we are aware of only one prospective
study analysing data of 70 consecutive patients [9].
None of those series focused on image quality and
diagnostic confidence in different BW groups because
of the relatively low numbers of patients included.
Results of our large-scale prospective randomised trial
on 501 patients provide evidence that subjective image
quality and diagnostic confidence for detecting PE with
normal-dose CTPA at 100 kVp and with low-dose
CTPA at 80 kVp tube energy, using a reduced radiation
dose by 30 % and a reduced iodine load by 25 %, do
not differ significantly up to a BW of 100 kg. The
weight limit of 100 kg seems to be valid for the
80 kVp CTPA protocol, as we found no significant
difference in subjective image quality and diagnostic
confidence compared with the normal-dose protocol in
any of the BW subgroups. Nor were these parameters
for both protocols significantly different in obese pa-
tients with BMI >30 kg/m2. The number of detected PE
with both CTPA protocols was not different at all ram-
ification levels. These data confirm findings of former
experimental and retrospective studies [8, 22].
Despite the reduced iodine flux by 25 % in the low-
dose group, the mean attenuation in the pulmonary
trunk did not differ from that measured in the normal-
dose group. As a net effect, together with the increased
image noise, CNR was lower in the low-dose group.
These results are well explained by the physical prop-
erties of iodine at low kVp and consistent with
measurements in a chest phantom predicting increased
attenuation by 25 % at constant iodine concentration
when reducing tube voltage from 100 to 80 kVp [3,
23, 24]. On the contrary, an initial retrospective com-
parison in 90 patients showed that CTPA using 80 kVp
and less CM by 25 % provided higher vessel attenua-
tion and a similar CNR to the standard CTPA protocol
at 100 kVp [7]. The current prospective randomised
trial, with its markedly higher numbers of patients,
provides more reliable data.
The analysis of the FOM, a parameter characterising
improvement of CNR per exposure risk to the patient,
showed that kVp reduction is more important in thin
patients than in large patients, as FOM was higher at
lower BW. As BW rises, scattering becomes an impor-
tant factor and leads to higher image noise. A reduced
iodine signal at a higher BW because of beam harden-
ing also deteriorates CNR in large patients [25]. The
fact that FOM did not differ between the normal-dose
and low-dose groups in any weight classes indicates that
the lower CNR at 80 kVp is well in balance with the
reduced radiation dose compared with the 100 kVp
group. The analysis of accuracy in the REDOPED study
did not find any significant difference between CTPA
protocols [26].
Our trial had some limitations. Most important, only
patients weighing less than 100 kg were included in the
Table 3 Subjective image quality as rated by the readers with causes for diminished subjective image quality in the normal-dose and low-dose groups
Normal-dose group Low-dose group P a
Reader 1 Reader 2 Reader 1 Reader 2
Image quality Subjective quality rating 4.58±0.64 3.70±0.90 4.45±0.75 3.60±0.96 0.156
5.0 [4.0; 5.0] 4.0 [3.0; 4.0] 5.0 [4.0; 5.0] 4.0 [3.0; 4.0]
Patients with grade 3 or less 17 93 23 94 0.403
Cause for reduced image quality High image noise 5 7 9 29 <0.001
CM-bolus related 13 9 12 14 0.472
Artefacts (respiratory, movement, metallic) 6 33 9 26 0.747
Changes in lung parenchyma 7 53 9 55 0.550
Pleural effusion 2 10 6 7 0.769
Other 0 0 0 0 1.0
Total 33 112 45 131 0.001
Data for subjective image quality are mean ± standard deviation, followed by the median and the quartile range in brackets. Other data are number of
patients. Readers often noted more than one cause for reduced image quality in the same patient
a P values for differences between the normal-dose and low-dose groups, based on averaged data over both readers
Fig. 2 Box-and-whisker plots depicting objective and subjective
parameters assessed with normal-dose (group A) and low-dose CTPA
(group B) at various body weights. Themiddle point of the box represents
the mean, the box values represent the standard error, and the whiskers
represent the standard deviation. CNR contrast-to-noise ratio
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study, since results from phantom experiments predicted
a significantly decreased image quality above this BW.
Our subjective impression in real patients was that the
80 kVp protocol would in fact result in an image noise
level that would impede diagnosis above 100 kg.
However, there are no objective data to support this
observation. We cannot explain the unexpected differ-
ence in the sex ratio between the study groups, as
analysis of study records did not reveal systemic error
or protocol violation during patient enrolment. This
difference, however, did not influence the comparisons
within the various weight subgroups. Although the trial
included 501 individuals, the number of patients with a
BW of <60 kg and 90-99 kg or with a BMI >30 kg/m2
was relatively low, with a negative impact on the sta-
tistical power in these subgroups. Our CT unit was
equipped with a relatively old detector and did not use
iterative image reconstruction, since at the start of our
study this tool was not yet widely available. This shows
that a significant dose reduction is possible even with
older CT units. From some recently published encour-
aging results on low kVp CTPA combined with iterative
reconstruction [19], we are convinced that the latest
hardware would result in significant improvement of
image quality with the 80 kVp protocol, which could
facilitate its wider acceptance among radiologists or
may permit the examination of patients weighing more
than 100 kg. The injection time of 25 s with both
CTPA protocols was rather long. More rapid scanning
techniques requiring a shorter contrast bolus enable a
decrease in total iodine load to the patient. We also note
that the applicability of low tube voltage can be shifted
towards higher BWs when using stronger real time mAs











Fig. 3 Transversal 1-mm-thick
slices at the level of the main
pulmonary artery to demonstrate
image quality with normal-dose
CTPA (A, B, C, D, E) and low-
dose CTPA (F, G, H, I, J) in
patients from various bodyweight
groups. The window level was set
at 100 HU and the window width
at 500 HU in each case. Body
weights were as follows: A 51 kg,
B 62 kg, C 71 kg, D 89 kg, E
94 kg, F 56 kg, G 66 kg, H 73 kg,
I 82 kg, J 92 kg. Pulmonary
emboli are seen in imagesA, C, D,
E, G, H, I and J
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low-dose protocol for further optimisation. Since CTPA
examinations have the primary goal to rule in or out
PE, our quality assessment focused on the pulmonary
arteries. Although analysis of image quality in the me-
diastinum and lung parenchyma was no subject of this
investigation, our experience shows that major patholo-
gies can be excluded in both of those localisations at
80 kVp, even in filtered back projection images.
In conclusion, 80-kVp CTPA using reduced radiation ex-
posure and a reduced CM dose does not significantly differ
from the normal-dose protocol at 100 kVp with regard to
subjective image quality or diagnostic confidence in any
BW class up to 100 kg. More recent technical implications
will enable further dose reduction and quality improvement of
the 80-kVp protocol.
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Table 4 Patient characteristics, image quality and diagnostic confidence in various BMI groups
BMI
<25 kg/m2 (n=247) 25-30 kg/m2 (n=182) >30 kg/m2 (n=72) P
Female/male (n) group A 50/64 36/67 21/17 0.029
group B 78/55 27/52 25/9 <0.001
P 0.020 0.913 0.107
Weight (kg) group A 64.3±10.3 80.6±8.3 89.3±7.2 <0.001
group B 61.8±9.9 78.6±8.5 86.5±6.9 <0.001
P 0.312 0.732 0.797
BMI (kg/m2) group A 22.0±2.3 27.2±1.4 32.2±2.7 <0.001
group B 21.8±2.3 26.9±1.4 32.5±2.3 <0.001
P 0.909 0.935 0.995
Attenuation in the pulmonary trunk (HU) group A 415.2±111 375.6±107 328.6±89 <0.001
group B 427.0±121 382.6±109 367.7±111 0.004
P 0.967 0.999 0.699
Noise (HU) group A 33.4±7.2 37.5±7.9 38.4±8.6 <0.001
group B 43.5±9.8 49.9±12.9 50.7±13.1 <0.001
P <0.001 <0.001 <0.001
CNR group A 11.3±3.6 9.0±3.0 7.7±2.9 <0.001
group B 9.0±3.0 7.0±2.9 6.5±2.3 <0.001
P <0.001 <0.001 0.518
SSDE (mGy) group A 6.4±1.2 7.0±1.1 7.4±1.1 <0.001
group B 4.6±1.1 5.0±0.6 5.6±0.8 <0.001
P <0.001 <0.001 <0.001
FOM group A 23.2±16.3 13.1±8.4 9.0±6.1 <0.001
group B 20.9±16.6 11.8±10.7 8.7±5.6 <0.001
P 0.765 0.991 1.0
Subjective image quality group A 4.1±0.7 4.0±0.7 4.2±0.5 0.454
4.5 [3.5; 4.5] 4.0 [3.5; 4.5] 4.5 [4.0; 4.5]
group B 4.1±0.7 4.1±0.7 4.0±0.9 0.735
4.5 [3.5; 4.5] 4.0 [3.5; 4.5] 4.5 [3.5; 4.5]
P 1.0 0.996 0.798
Diagnostic confidence group A 2.6±0.6 2.5±0.5 2.6±0.6 0.899
3.0 [2.5; 3.0] 2.5 [2.0; 3.0] 3.0 [2.5; 3.0]
group B 2.6±0.6 2.5±0.6 2.4±0.7 0.503
3.0 [2.3; 3.0] 3.0 [2.0; 3.0] 3.0 [2.0; 3.0]
P 1.0 1.0 0.855
Data are mean ± standard deviation. For subjective image quality and diagnostic confidence, the median is also given with the lower and upper quartiles
in brackets
BMI body mass index, SSDE size specific dose estimate, FOM figure of merit
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Some study subjects or cohorts have been previously reported by Szucs-
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